Pharma & Healthcare
Pharma & Healthcare is becoming a key area for investment with an aging population and growing demands for medicine and better healthcare. PMSI has specialisms within the sector including:
Manufacturing, supply chain, packaging
IT software / middleware, medical products, orthopaedic implants
Please click on the logos to learn more about our work in this sector
PMSI has worked with LDC throughout their investment in NRS. We provided a full CDD report to support the initial investment, which involved assessing the market, policy environment, selection criteria, competitive landscape and the achievability of the business plan. We also provided a full customer referencing update to support the partial exit, speaking to all key customers to test satisfaction and to get their views on market changes and developments.
NRS Healthcare is a market-leading outsourced provider of specialist community healthcare equipment and services to the NHS and local authorities. The firm’s products and services help people with mobility issues to be self-sufficient within the home to either delay or prevent more expensive residential or acute care.
LDC backed the £24million management buy-out of the business from multi-channel retailer Findel PLC in 2012 and partially exited the investment in 2014 after the business secured investment from H2 Equity Partners.
During LDC’s investment, revenues at NRS Healthcare increased 46 per cent from £90million in 2013 to £132million (2014). On realisation, LDC achieved a 2.8x return on money invested. In October 2016 NRS Healthcare were ranked 208th in the Sunday Times Grant Thornton Top Track 250 league table.